Follow
Sarah Jane Larkin
Sarah Jane Larkin
Verified email at oncology.ox.ac.uk
Title
Cited by
Cited by
Year
Pathology and pathogenesis of craniopharyngiomas
SJ Larkin, O Ansorge
Pituitary 16 (1), 9, 2013
1442013
Noninvasive quantification of 2-hydroxyglutarate in human gliomas with IDH1 and IDH2 mutations
UE Emir, SJ Larkin, N de Pennington, N Voets, P Plaha, R Stacey, ...
Cancer research 76 (1), 43-49, 2016
1312016
Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas
OA Sarah Larkin, Raghava Reddy, Niki Karavitaki, Simon Cudlip, John Wass
European Journal of Endocrinology 168, 491, 2013
1292013
Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance
PJ Thornalley, S Waris, T Fleming, T Santarius, SJ Larkin, ...
Nucleic acids research 38 (16), 5432-5442, 2010
1252010
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study
D Iacovazzo, R Caswell, B Bunce, S Jose, B Yuan, ...
Acta neuropathologica communications 4, 1-12, 2016
1162016
BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma
SJ Larkin, V Preda, N Karavitaki, A Grossman, O Ansorge
Acta Neuropathologica 127 (6), 927, 2014
1112014
Rathke's cleft cyst
S Larkin, N Karavitaki, O Ansorge
Handbook of clinical neurology 124, 255-269, 2014
662014
Development and microscopic anatomy of the pituitary gland
S Larkin, O Ansorge
612017
Reversal of hyperglycemia‐induced angiogenesis deficit of human endothelial cells by overexpression of glyoxalase 1 in vitro
U Ahmed, D Dobler, SJ Larkin, N Rabbani, PJ Thornalley
Annals of the New York Academy of Sciences 1126 (1), 262-264, 2008
572008
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy
H Khalique, R Baugh, A Dyer, EM Scott, S Frost, S Larkin, ...
Journal for immunotherapy of cancer 9 (4), 2021
402021
Improved localization for 2-hydroxyglutarate detection at 3 T using long-TE semi-LASER
A Berrington, NL Voets, P Plaha, SJ Larkin, J Mccullagh, R Stacey, ...
Tomography 2 (2), 94-105, 2016
332016
The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis
V Preda, SJ Larkin, N Karavitaki, O Ansorge, AB Grossman
Endocrine pathology 26, 1-8, 2015
332015
A comparison of 2‐hydroxyglutarate detection at 3 and 7 T with long‐TE semi‐LASER
A Berrington, NL Voets, SJ Larkin, N de Pennington, J Mccullagh, ...
NMR in Biomedicine 31 (3), e3886, 2018
302018
Pathology and pathogenesis of pituitary adenomas and other sellar lesions
S Larkin, O Ansorge
Endotext [Internet], 2017
302017
A noninvasive comparison study between human gliomas with IDH1 and IDH2 mutations by MR spectroscopy
X Shen, NL Voets, SJ Larkin, N de Pennington, P Plaha, R Stacey, ...
Metabolites 9 (2), 35, 2019
272019
Recent advances in molecular pathology of craniopharyngioma
S Larkin, N Karavitaki
F1000Research 6, 2017
262017
Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas
KM Larkin SJ, Ferrau F, Karavitaki N, Hernández-Ramírez LC, Ansorge O ...
European Journal of Endocrinology, 2014
152014
Endotext
S Larkin, O Ansorge, KR Feingold, B Anawalt, A Boyce, G Chrousos, ...
South Dartmouth (MA): MDText. com, Inc. Available from:, 2000
122000
The improved detection of 2-hydroxyglutarate in gliomas at 7T using high-bandwidth adiabatic refocusing pulses
UE Emir, SJ Larkin, N de Pennington, N Voets, P Plaha, R Stacey, ...
Proceedings of the 23rd Annual Meeting of ISMRM, Toronto, Canada 2236, 2013
22013
The benefits of in vivo 2-hydroxyglutarate detection using semi-LASER at 7T and 3T: a comparative study
A Berrington, SJ Larkin, N de Pennington, NL Voets, P Plaha, R Stacey, ...
ISMRM. Singapore, 2016
12016
The system can't perform the operation now. Try again later.
Articles 1–20